Sex-specific differences in 30-day outcomes following primary total hip replacement in 86,684 patients.


Journal

Hip international : the journal of clinical and experimental research on hip pathology and therapy
ISSN: 1724-6067
Titre abrégé: Hip Int
Pays: United States
ID NLM: 9200413

Informations de publication

Date de publication:
Sep 2023
Historique:
medline: 8 9 2023
pubmed: 16 7 2022
entrez: 15 7 2022
Statut: ppublish

Résumé

Although differential outcomes based on sex are widespread in medicine and surgery, evaluation of sex-specific differences in the field of orthopaedic surgery in general - and arthroplasty in particular - are lacking. We hypothesised that morbidly obese male and female patients would have differing risks of surgical complications following primary total hip replacement. We reviewed data contained within the American College of Surgeons National Quality Improvement Program (ACS-NSQIP) database from 2015 through 2018, inclusive. A multivariable binary logistic regression model was used to determine the adjusted odds ratios (OR) of relevant variables on primary and secondary outcomes. A total of 86,684 patients undergoing THR were identified, of whom 9972 patients (4095 male and 5877 female) were morbidly obese. Among morbidly obese patients, odds of surgical site infection were higher in females than males within 30 days of surgery (adjusted OR 1.40; 95% CI, 1.10-1.79; Among patients with morbid obesity, the risk of surgical site infection and reoperation within the first 30 days is greater in women as compared to men. Future research must address whether this early increased risk among morbidly obese women persists in the longer term, and whether it results in compromised function or quality of life.

Identifiants

pubmed: 35836327
doi: 10.1177/11207000221110786
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

828-832

Auteurs

Harman Chaudhry (H)

Division of Orthopaedic Surgery, Department of Surgery, University of Toronto, ON, Canada.

Seper Ekhtiari (S)

Division of Orthopaedic Surgery, Department of Surgery, McMaster University, Hamilton, ON, Canada.

Bheeshma Ravi (B)

Division of Orthopaedic Surgery, Department of Surgery, University of Toronto, ON, Canada.

Veronica Wadey (V)

Division of Orthopaedic Surgery, Department of Surgery, University of Toronto, ON, Canada.

Sebastian Tomescu (S)

Division of Orthopaedic Surgery, Department of Surgery, University of Toronto, ON, Canada.

John Murnaghan (J)

Division of Orthopaedic Surgery, Department of Surgery, University of Toronto, ON, Canada.

Raman Mundi (R)

Division of Orthopaedic Surgery, Department of Surgery, University of Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH